Asosiy kontentga oʻtish
Maqola

Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐<i>a</i>]thiazolo[5,4‐<i>d</i>]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease

Yan ZengState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, ChinaLifei NieState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry Chinese Academy of Sciences Urumqi ChinaLiu LiuState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry Chinese Academy of Sciences Urumqi ChinaChao NiuState Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, ChinaYi LiUniversity of Chinese Academy of Sciences Beijing ChinaKhurshed BozorovFaculty of Chemistry, Samarkand State University, Samarkand, UzbekistanJiangyu ZhaoUniversity of Chinese Academy of Sciences Beijing ChinaJingshan ShenShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, ChinaHaji Akber AisaUniversity of Chinese Academy of Sciences Beijing China

Ochiq kirish: yoʻq

ABI

Annotatsiya

Abstract A novel of 40 pyrrolo[1,2‐ a ]thiazolo[5,4‐ d ]pyrimidinone derivatives were designed and synthesized as cholinesterase inhibitor agents. The in vitro enzyme assays proved that most of the compounds effectively inhibited cholinesterases in the micromolar range with little cytotoxicity. Compound G15 exhibited the best inhibitory activity against acetylcholinesterase with an IC 50 of 2.69 ± 0.17 μM. Kinetic analysis and molecular modeling testified the competitive inhibition manner of G15 was more likely to bind to the active center of acetylcholinesterase. Thus, compound G15 can be considered as promising lead compounds or candidates for the development of novel drugs against Alzheimer's disease.

Hali tarjima qilinmagan

Mavzular

Identifikatorlar

Iqtiboslar va manbalar